Eugine Lee's research discovered a small molecule inhibitor (C3) of nuclear β‐catenin activity that inhibits the growth of prostate cancer cells by blocking the interaction between β‐catenin/T‐cell factor and β‐catenin/AR protein. This evidence concerns the gene AR and prostate carcinoma.